Hazardous Drugs: Draft NIOSH List of Hazardous Drugs in Healthcare Settings, 2020; Procedures; and Risk Management Information
May 2020
NIOSH Docket Number 233-C, CDC-2020-0046
The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), in the Department of Health and Human Services announced that the following draft documents were available for public comment: (1) NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings (Procedures); (2) NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 (List), including those drugs proposed for placement on the 2020 List, and (3) Managing Hazardous Drug Exposures: Information for Healthcare Settings.
To view the notice and related materials, visit http://www.regulations.gov and enter CDC-2020-0046 in the search field and click “Search.”
Reference Documents
- Federal Register Notice: Federal Register Notice 4-27-2023 [PDF – 309 KB]
- Federal Register Notice: Federal Register Notice 6-19-2020 [PDF – 248 KB] — Extension of Comment Period
- Federal Register Notice: Federal Register Notice 5-1-2020 [PDF – 358 KB]
- Background Information:
- Final Document: Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings [PDF – 1 MB]
- Final Document: Managing Hazardous Drug Exposures: Information for Healthcare Settings [PDF – 2 MB]
- Draft – NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings [PDF – 894 KB]
- Draft NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 [PDF – 1 MB]
- Draft – Managing Hazardous Drug Exposures: Information for Healthcare Settings [PDF – 4 MB]